T. Rowe Price CEO: $20B in client outflows ‘clearly the missing ingredient’

T. Rowe's CEO Rob Sharps, in discussing the firm's second quarter results, said outflows should get better in 2024 and that the company is poised to return to organic growth in 2025.

Insights: Greater Dayton community projects funded, slated for 2024

Lange Real Estate planning a residential development just west of Wichita

Orlando entrepreneur Craig Mateer lists Windermere mansion. The price tag is $12M. (PHOTOS)

High-profile Los Angeles executive departs Wells Fargo

Calta Group buys Coral Gables apartment building for $12 million to redevelop

Exclusive: New sports facilities in South Florida to host players who pay

Hotel near Busch Gardens sells for just over $14.3 million

These were Greater Cincinnati’s most expensive home sales of 2022: PHOTOS

T. Rowe Price CEO: $20B in client outflows ‘clearly the missing ingredient’

Previous Federated Hermes CEO talks strength in numbers, both Q2 results and family dynamics

Next Biogen to buy DFW rare disease firm for $7.2B

firststargroup

Kotek touts $500M Oregon housing plan at Leadership Summit

Retirement plans see boost as states mandate IRAs and tax credits lower costs

Norton Healthcare data breach affected more than 2 million people

Houston-based cell therapy company FibroBiologics files to go public

Suggested Posts

Eastern Bank reports record profits in 2022, but warns of belt-tightening ahead

Bach Society of Dayton delights audiences in collaborative shows

Holy Names University in talks with buyer for Oakland campus who would preserve educational use

SIlicon Valley startup Alcatraz AI raised $25M for its door security service that works like Apple’s Face ID

J Street property next to Anthem Properties’ Downtown Sacramento Envoy project hits the market

Public hearings set for 351-acre Woodland Research & Technology Park

MENU

FirstStar Group

More Stories

Hawaii Pacific FCU merges with Aloha Pacific FCU

Previous Federated Hermes CEO talks strength in numbers, both Q2 results and family dynamics

Next Biogen to buy DFW rare disease firm for $7.2B

firststargroup

Related Posts

Suggested Posts

MENU

FirstStar Group

More Stories